“Raleigh-based Salix Pharmaceuticals has agreed to be acquired by Canadian drugmaker Valeant Pharmaceuticals in a deal valued at some $14 billion. The boards of both companies have already agreed to the terms, which were announced Sunday” according to WRAL TechWire. Valeant said in a statement that the acquisition means strong growth, as Salix has focused on developing drugs to treat gastrointestinal diseases. For more information, please visit: http://wraltechwire.com/raleigh-based-salix-pharmaceutical-being-acquired-in-14b-deal/14464120/